Prenatal diagnosis of mucolipidosis II using fetal cells in amniotic fluid

Prenatal diagnosis of mucolipidosis II using fetal cells in amniotic fluid - Prenatal diagnosis of mucolipidosis II using fetal cells in amniotic fluid

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000043462

Enrollment

Registered

2021-03-01

Start date

2017-09-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mucolipidosis II

Interventions

PCR and direct sequencing of the affected gene (GNPT) and indirect diagnosis using microsatellite analysis or Karyomapping

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Pregnant woman who previously delivered the baby with mucolipidosis II

Exclusion criteria

Exclusion criteria: nothing

Design outcomes

Primary

Measure	Time frame
whether fetus will be affected or not	—

Countries

Japan

Contacts

Public ContactTsuyoshi Baba

Sapporo Medical University Obstetrics and Gynecology

tbaba@sapmed.ac.jp011-611-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026